Healios KK Ord Shs HLOSF

Healthcare Biotechnology

Healios KK is a Japan-based company mainly engaged in business in the somatic stem cell regenerative medicine field and in the iPSC regenerative medicine field, which involves research, development and manufacture of regenerative medicine products (iPSC regenerative medicines) utilizing technologies related to induced pluripotent stem cells (iPS cells, iPSCs). The somatic stem cell regenerative medicine field develops and markets cell therapy drugs for acute stroke and acute respiratory distress syndrome using MultiStem, a somatic stem cell product for which the Company holds patent and patent licensing rights. The iPSC regenerative medicines include the creation of universal donor cells (UD), next-generation iPSCs that reduce the risk of immune rejection regardless of human leukocyte antigen (HLA) type using gene editing technology.

PINL:HLOSF - Post by User

Healios KK Ord Shs > Halelujah!

<< Previous

Bullboard Posts

Next >>

Comment by ventureveston Oct 06, 2010 4:19pm

202 Views

Post# 17537042

RE: Halelujah!

I think this is a reflection of the cuting of the tie between Mineralfiels and HLO.... Glad I filed a complaint regarding that relationship. Note that as soon as the new placee was acknowldged to be Pinetree how the selling stopped and investors had the confidence to purchase some stock.

With the present float and advanced projects trading over a dollar should be in the cards.... That is where Mineralfields will dump the balance of their stock.... Once that has been done HLO should make a much higher valuation. JMHO

Will be keeping the balance of my position for the play in the project.

<< Previous

Bullboard Posts

Next >>

Canopy Growth nears adjusted EBITDA profitability in Q2 2025